Levothyroxine Supplementation for Heart Transplant Recipients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This will be a prospective, randomized study performed at a single tertiary referral academic medical center (University of California San Francisco, CA), evaluating the survival benefits of levothyroxine compared with no levothyroxine for patients who have undergone heart transplant. It will be double-blinded and placebo-control; participants will be randomized to receive levothyroxine or receive no levothyroxine.
Epistemonikos ID: d71726e3f463995e78165dd713cd7ed99846034f
First added on: Jun 01, 2024